Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jan 25;20:21. doi: 10.1186/s13059-019-1621-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 6 — Melanoma cell lines with high expression of SOX10 are not sensitive to SOX9 knockdown. a Left panel: log-fold change for clean guide A3 targeting SOX9 as a function of SOX9 expression. Right panel: log-fold change for clean guide B1 targeting SOX10 as a function of SOX10 expression. Two melanoma cell lines were selected for SOX9 and SOX10 knockdowns validation: Malem-3M and UACC-62 (in red). One colorectal carcinoma (LS1034) was selected to measure SOX9 siRNAs knockdown efficiency. b Cell viability of two melanoma cell lines after transfection with small interfering RNAs (siRNAs), relative to the non-targeting control (siNTC) treatment. c Relative SOX10 mRNA expression levels, detected by qPCR, after transfection of the indicated siRNAs, for two melanoma cell lines. Expression levels are normalized to GAPDH mRNA detected in the same sample, and then expressed as a fold change with respect to the siNTC treatment. d Relative SOX9 mRNA expression levels, detected by qPCR, after transfection of the indicated siRNAs, for the colorectal carcinoma cell line LS1034